Bhavana Pothuri

ORCID: 0000-0003-4578-2061 · 3 papers in corpus
article 2020
Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection
Gynecologic oncology reports ·doi:10.1016/j.gore.2020.100644

Cancer antigen 125 (CA 125) is a transmembrane glycoprotein expressed on the surface of germinal epithelium and other tissues derived from embryonic coelomic epithelium (Bischof, 1993). CA 125 is a useful biomarker to detect treatment respo…

2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.06.001

The COVID-19 pandemic has challenged our ability to provide timely surgical care for our patients. In response, the U.S. Surgeon General, the American College of Srugeons, and other surgical professional societies recommended postponing ele…

2019
Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapy.
Gynecologic oncology reports ·doi:10.1016/j.gore.2018.11.004

We describe a case of the first successful treatment of platinum refractory clear cell ovarian cancer with secondary cytoreductive surgery and placement of Calypso transponders to facilitate post-operative volumetric arc radiation therapy. …